For example, a virulent and resistant pathogen causing community-acquired pneumonia, such as methicillin-resistant Staphylococcus aureus (MRSA), acquired ... An ideal oral antibiotic for switch ...

The intravenous options for MRSA are generally limited to ... pulmonary exacerbations utilizes combinations of oral, inhaled and intravenous antibiotic agents. Chronic use of aerosolized ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...

Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...

Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma. The molecular mechanisms underlying tumour initiation ...